$SFIX

Bacos Anthony sold $286K of SFIX

Bacos Anthony (Chief Prod/Technology Officer) sold 70,000 shares of Stitch Fix, Inc. (SFIX) at an average of $4.09 ($4.09–$4.09, $0.29M total) across 2 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bacos Anthony
Published Aug 5, 2026, 9:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SFIX
Neutral
high confidence
Mentioned
$SFIX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SFIXNeutralLow
01

Why it matters

The disclosed sale is a new, concrete datapoint for insider activity, but it is not tied to new guidance, earnings, or a corporate event in the text.

02

Market read

Traders may note the insider sale as a sentiment input, but the 10b5-1 framing reduces the informational content.

03

What to watch

The article does not state whether other insiders sold/bought around the same time, nor does it provide any new company fundamentals that would validate a stronger market reaction.

Relevance 3/10Novelty 3/10Timing: filed Aug 5, covering Aug 3 sales

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Stitch Fix, Inc.

Company-level read

Ticker impact

$SFIXNeutralHigh confidence
Context

Stitch Fix Form 4 shows CFO/CTO officer Bacos Anthony sold 70,000 shares in open-market transactions under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a disclosed insider sale with a pre-arranged 10b5-1 plan, and the article contains no accompanying operational, guidance, or regulatory catalyst.

Market effects

Minimal, as this is company-specific insider activity without sector-wide information.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect diversification or scheduled liquidity rather than bearish expectations.

Key entities

  • Stitch Fix, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Bacos Anthony

    Chief Prod/Technology Officer who sold shares under a 10b5-1 plan.

Related articles

$SFIXMedAI 8/10

Why Stitch Fix Stock Surged Today

Stitch Fix shares rose 15.69% on Thursday after the company reported fiscal 2026 Q3 results that beat investor expectations. Revenue increased 4.7% to $340 million; net revenue per active client rose 6.6% to $578. Net loss narrowed to $1.5 million, free cash flow was $6.5 million, and adjusted EBITDA rose 20% to $13.2 million. Stitch Fix raised full-year guidance to about $1.35 billion revenue and $49–$52 million adjusted EBITDA, with positive free cash flow.

$ORCLMedAI 8/10

Futures Rise, Oil Drops As US Ends Iran Strikes

US equity futures rose as tech and small caps gained after US Central Command said strikes against Iran were complete, easing concerns about further escalation and the Strait of Hormuz reopening. S&P futures rose 0.7% and Nasdaq 100 1.1%; bond yields fell 1–3bp. Brent slipped ~1% below $92; WTI fell to $88.87. Oracle shares fell ~8% after higher-than-estimated capex; Navan jumped 19% after raising revenue outlook.